Wednesday, February 10, 2010, 10:00pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

AstraZeneca plc (AZN)

At 5:01AM SGT: 44.11 USD   0.00 (0.00%)  
 MORE ON AZN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ASTRAZENECA PLC ADS (NYSE:AZN) Delayed quote dataEdit
Pre-Market: 44.17 Up 0.06 (0.14%) as of 9:11pm SGT on 02/10/10
Last Trade:44.11 USD
Trade Time:5:01AM SGT
Change: 0.00 (0.00%)
Prev Close:44.11
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:46.60
Day's Range:N/A - N/A
52wk Range:29.96 - 50.70
Volume:200
Avg Vol (3m):1,465,750
Market Cap:64.00B
P/E (ttm):8.86
EPS (ttm):4.98
Div & Yield:2.30 (5.21%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AZN to Portfolio   Download Data

 HEADLINES 
•Biotech Stocks: Cell Therapeutics, AstraZeneca lead drug stocks
at MarketWatch (Wed 2:31am)
•AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Wed 1:50am)
•Label Expansion for AZN Drug
Zacks.com (Wed 12:53am)
•Rewriting AstraZeneca's Script
at CNBC (Wed 12:31am)
•Europe Launches Probe into Pharma Deals
at BusinessWeek (Tue 11:52pm)
•Biotech Stocks: Drug stocks gain; Cell Therapeutics rebounds
at MarketWatch (Tue 11:23pm)
•Cholesterol Drug Approved for People Without High Cholesterol
at The Wall Street Journal Online (Tue 9:53pm)
•[$$] Wider FDA Approval Could Boost Crestor Sales
at The Wall Street Journal Online (Tue 9:27pm)
•[$$] Great Off-the-Radar Stocks
at Barrons.com (Tue 7:00pm)
•AstraZeneca says FDA approves Crestor indication
at MarketWatch (Tue 3:21pm)
•Crestor Wins Approval as a Drug to Prevent Heart Disease
at The New York Times (Tue 1:04pm)
•US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
PR Newswire (Tue 8:09am)
•AstraZeneca gets OK for expanded Crestor use
AP (Tue 8:02am)
More Headlines for AZN...
 ANALYST 
EPS Est (next year) (Dec-09) :6.44
EPS Est (in 2 years) (Dec-10) :6.10
Avg Rec (current)*:3.2
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
AstraZeneca plc discovers, develops, manufactures, and markets prescription pharmaceuticals and biological products in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices